Inhibiting PAD2 Enhances the Anti-Tumor Effect of Docetaxel in Tamoxifen-Resistant Breast Cancer Cells
Journal of Experimental and Clinical Cancer Research - United Kingdom
doi 10.1186/s13046-019-1404-8
Full Text
Open PDFAbstract
Available in full text
Date
October 10, 2019
Authors
Publisher
Springer Science and Business Media LLC